Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second.

Vertex's first loss in years is a big nothingburger. Vertex Pharmaceuticals (VRTX 2.03%) has churned out nice profits quarter after quarter for years. The big biopharmaceutical company's cystic fibrosis (CF) franchise made it easy. However, Vertex announced its second-quarter results following the market close on Thursday. Lo and behold, the company posted a net loss of $3.6 billion, based on generally accepted accounting principles (GAAP). Its non-GAAP loss was $3.3 billion. Should investors worry about th ...